GTB-5550

· Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GTB-5550, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: GTB-5550 in Advanced Solid Tumors [Phase 1]